Target Name: PSMB4
NCBI ID: G5692
Review Report on PSMB4 Target / Biomarker Content of Review Report on PSMB4 Target / Biomarker
PSMB4
Other Name(s): proteasome (prosome, macropain) subunit, beta type, 4 | PROS26 | proteasome subunit, beta type, 4 | Proteasome beta chain | proteasome beta chain | multicatalytic endopeptidase complex beta chain | proteasome subunit HsN3 | proteasome subunit beta7 | macropain beta chain | 26 kDa prosomal protein | PSB4_HUMAN | proteasome chain 3 | Proteasome subunit beta type-4 | Proteasome subunit, beta type, 4 | Proteasome subunit HsN3 | PROS-26 | Multicatalytic endopeptidase complex beta chain | testis tissue sperm-binding protein Li 79P | HN3 | proteasome 20S subunit beta 4 | Proteasome 20S subunit beta 4 | hsBPROS26 | PRAAS3 | Proteasome chain 3 | proteasome subunit beta 4 | HsBPROS26 | HsN3 | Macropain beta chain

PSMB4: A Potential Drug Target and Biomarker for Proteasome-Mediated Signaling

Introduction

Proteasomes, also known as autophagosomes, are complex protein structures that play a crucial role in regulating various cellular processes, including DNA replication, gene expression, and stress responses. They are composed of a protein subunit (尾2) and a nucleotide subunit (伪2) , which are involved in the formation of the proteasome complex. The 尾2 subunit is known as PSMB4, and it has been identified as a potential drug target and biomarker for various diseases.

PSMB4: Structure and Function

PSMB4 is a 186-kDa protein that is composed of 1165 amino acid residues. It has a characteristic 伪-helices and a distinct 尾-sheet, which are believed to contribute to its stability and functions. PSSMB4 is predominantly localized to the endoplasmic reticulum ( ER) and is involved in the regulation of various cellular processes, including DNA replication, gene expression, and stress responses.

PSMB4 has been shown to play a critical role in the formation and maintenance of the proteasome complex. It is a key component of the 尾2 subunit, which is responsible for organizing and stabilizing the complex. Studies have shown that the 尾2 subunit of PSSMB4 is involved in the formation of the nucleotide-protein complex, which is critical for the subsequent cleavage of target proteins by the proteasome.

PSMB4 has also been shown to be involved in the regulation of cellular stress responses. During stress, the levels of PSSMB4 in the ER increase, and it is involved in the signaling pathways that regulate stress-induced cellular changes, including the translation of mRNAs, the expression of stress-responsive genes, and the cellular response to stress-induced alterations in ion homeostasis.

PSMB4 as a Drug Target

PSMB4 has been identified as a potential drug target due to its involvement in various cellular processes that are associated with the development of various diseases. One of the primary targets of PSSMB4 is the regulation of cellular signaling pathways, which are critical for the development of cancer , neurodegenerative diseases, and other chronic illnesses.

Studies have shown that PSSMB4 is involved in the regulation of several signaling pathways that are associated with the development of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, PSSMB4 has been shown to be involved in the regulation of the PI3K /Akt signaling pathway, which is associated with the development of various cancers.

In addition to its involvement in signaling pathways, PSSMB4 has also been shown to be involved in the regulation of cellular processes that are critical for the development of neurodegenerative diseases. For example, PSSMB4 has been shown to play a role in the regulation of the neurotransmitter synthesis and release, which is critical for the development of neurotransmitter-dependent disorders.

PSMB4 as a Biomarker

PSMB4 has also been identified as a potential biomarker for various diseases. Its involvement in the regulation of cellular processes that are critical for the development of various diseases makes it an attractive candidate for use as a biomarker.

Studies have shown that PSSMB4 is involved in the regulation of cellular processes that are critical for the development of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. In addition, PSSMB4 has also been shown to be involved in the regulation of cellular processes that are critical for the development of cancer, including the regulation of apoptosis.

Conclusion

PSMB4 is a protein that is involved in

Protein Name: Proteasome 20S Subunit Beta 4

Functions: Non-catalytic component of the 20S core proteasome complex involved in the proteolytic degradation of most intracellular proteins. This complex plays numerous essential roles within the cell by associating with different regulatory particles. Associated with two 19S regulatory particles, forms the 26S proteasome and thus participates in the ATP-dependent degradation of ubiquitinated proteins. The 26S proteasome plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins that could impair cellular functions, and by removing proteins whose functions are no longer required. Associated with the PA200 or PA28, the 20S proteasome mediates ubiquitin-independent protein degradation. This type of proteolysis is required in several pathways including spermatogenesis (20S-PA200 complex) or generation of a subset of MHC class I-presented antigenic peptides (20S-PA28 complex). SMAD1/OAZ1/PSMB4 complex mediates the degradation of the CREBBP/EP300 repressor SNIP1

The "PSMB4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PSMB4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

PSMB5 | PSMB6 | PSMB7 | PSMB7P1 | PSMB8 | PSMB8-AS1 | PSMB9 | PSMC1 | PSMC1P2 | PSMC1P4 | PSMC1P9 | PSMC2 | PSMC3 | PSMC3IP | PSMC4 | PSMC5 | PSMC6 | PSMD1 | PSMD10 | PSMD10P1 | PSMD11 | PSMD12 | PSMD13 | PSMD14 | PSMD2 | PSMD3 | PSMD4 | PSMD4P1 | PSMD5 | PSMD6 | PSMD6-AS2 | PSMD7 | PSMD8 | PSMD9 | PSME1 | PSME2 | PSME2P2 | PSME2P3 | PSME3 | PSME3IP1 | PSME4 | PSMF1 | PSMG1 | PSMG1-PSMG2 heterodimer | PSMG2 | PSMG3 | PSMG3-AS1 | PSMG4 | PSORS1C1 | PSORS1C2 | PSORS1C3 | PSPC1 | PSPH | PSPHP1 | PSPN | PSRC1 | PSTK | PSTPIP1 | PSTPIP2 | PTAFR | PTAR1 | PTBP1 | PTBP2 | PTBP3 | PTCD1 | PTCD2 | PTCD3 | PTCH1 | PTCH2 | PTCHD1 | PTCHD1-AS | PTCHD3 | PTCHD3P1 | PTCHD3P2 | PTCHD4 | PTCRA | PTCSC2 | PTCSC3 | PTDSS1 | PTDSS2 | PTEN | PTENP1 | PTENP1-AS | PTER | PTF1A | PTGDR | PTGDR2 | PTGDS | PTGER1 | PTGER2 | PTGER3 | PTGER4 | PTGER4P2-CDK2AP2P2 | PTGES | PTGES2 | PTGES2-AS1 | PTGES3 | PTGES3L | PTGES3L-AARSD1 | PTGES3P1